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The much-awaited results from the Dutch-Belgian 
Randomized Lung Cancer Screening (NELSON) trial were 
published online on January 29 in the New England 
Journal of Medicine.' The study shows that CT lung cancer 
screening can significantly reduce the likelihood of high-risk 
smokers dying from lung cancer. 
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Lung cancer (both small cell and non-small cell) is the 
second most common cancer in both men and women 
(not counting skin cancer). In men, prostate cancer is more 
common, while in women breast cancer is more common. 
Lung cancer mainly occurs in older people. Most people 
diagnosed with lung cancer are 65 years or older; a very 
small number of people diagnosed are younger than 45 
years. The average age of people when first d iagnosed is 
about 70 years.2 
Lung cancer is by far the leading cause of cancer death 
among both men and women, making up almost 25% of all 
cancer deaths. Each year, more people die of lung cancer 
than of colon, breast, and prostate cancers combined.2 
On a positive note, the number of new lung cancer 
cases continues to decrease, partly because people are 
quitting smoking. Also, the number of deaths from lung 
cancer continues to drop due to people stopping smoking 
and advances in early detection and treatment. Early 
detection can only be achieved through routine screening 
of individuals at high-risk for lung cancer.2 
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The large-scale randomized controlled NELSON trial 
referred to above has investigated the potential benefits 
of CT lung screening among 15.792 individuals in the 
Netherlands and Belgium between the ages of SO and 
74 years, who had a high risk of lung cancer. Risk was 
estimated based on a current smoking history of 20 pack-
years or more or having quit smoking 10 years or less 
before screening. 
Participants were randomly assigned to either the CT 
lung cancer screening protocol or no screening. The four-
round screening protocol included a baseline CT exam 
followed by a CT exam at one, three, and five and a half 
years after the initial exam. 
Analysis of results of the NELSON study showed that 
screening led to a stat.istically significant reduction in total 
lung cancer deaths by 24% for men and 33% for women, 
compared with no screening. 
The study showed that CT lung cancer screening 
increased the likelihood of detecting lung cancer in the 
early stages: the proportion of cancers detected in stage IA 
or IB was 58.6% with CT lung screening and only 13.5% for 
the control group. 
LUNG CANCER IS BY FAR THE LEADING CAUSE OF CANCER DEATH AMONG 
BOTH MEN AND WOMEN, MAKING UP ALMOST 25% OF ALL CANCER DEATHS 
The same study also indicated that the screening 
interval can be readily increased from one year to two 
years without any impact on death rate. It was: also noted 
that an increased risk in the screened population was only 
evident after two years from the start of screening; this 
further confirmed that a bi-yearly CT scan is adequate as a 
screening method for lung cancer. 
Further observations from this study included that 
women fare better than men with treatment of early lung 
cancer and that the best criterion for assessing tumour 
growth is to measure tumour volume and not diameters. 
LUNG CJ NCEff DIAGNOSIS 
On CT scan, lung cancer presents mostly as a solid mass. 
Irregular borders are more indicative of a primary lung 
tumour, whilst smooth margins are more commonly seen 
with metastases from an extrapulmonary source. However, 
benign nodules may also exhibit smooth marg ins (Fig 1). 
Subsolid (not completely solid) pulmonary nodules, 
comprising pure ground-glass nodules (Fig 2) and part-solid 
(Fig 3) nodules, have a high risk of indolent malignancy; 
indolent malignancy refers to a slow growing type of cancer. 
Lung Imaging Reporting and Data System (Lung-RADS) 
nodule management guidelines are used to classify nodules 
based on their likeli hood of being malignant (Fig 4). These 
guidelines have been set based on expert opinion but lack 
independent validation. In fact, subsolid nodules classified 
as Lung-RADS categories 2 and 3 have a higher risk of 
malignancy than reported.3 
Figure 1. CT scan in 60·year-old man undergoing low-dose lung cancer 
screening. S.can shows a 6-mm solid nodule with irregular margins 
along the right minor fissure. This nodule was stable over 2 years of 
follow-up and most likely represents an intrapulmonary lymph node. 
Figure 2. CT scans. in a 57-year-old man undergoing low-dose lung 
cancer screening. (.a) Baseline scan shows a right upper lobe pure 
ground-glass nodule measuring 11 mm (arrow). Nodule was classified 
as Lung-RADS category 2. (b) CT scans obtained at second annual 
follow-up show th.at this nodule grew to 15 mm (arrow). Malignancy 
was subsequently diagnosed. 
Equivocal lung lesions that are either very small or 
indeterminate by their morphological appearance need to 
be followed up with CT. A change in size of the relevant 
lesion is best assessed by measuring lesion volume and not 
diameter. Increasing lesion size should lead to biopsy. 
Enlarged or heterogeneous mediastinal or hilar lymph 
nodes or those showing increasing size should also raise the 
level of suspicion in favour of malignant disease. 
IN1PORTJ..NCE OF E> RLY DIAGNOSIS 
Currently, the only way to improve outcome of lung 
cancer treatment is through early detection. Surgical 
excision is the most effective treatment for lung cancer 
thesynapse.net • 25 
Figure 3. CT scans in a 60-year-bld woman undergoing low-dose lung 
cancer screening CT. (a) Baseline scan shows a right lower lobe part· 
solid nodule· measuring 11 mm with 5-mm solid component (arrows). 
Nodule was classified as Lung-RADS category 3. (b) Scan obtained at 
second annual follow-up shows that nodule grew to 17 mm with 7 mm 
solid component (arrows). Malignancy was subsequently diagnosed. 
CLINICS AVAILABLE 
and it is only possible in the early stages of the disease. 
In addition, smaller cancers need less extensive surgery 
and consequently lead to lower morbidity. CT lung cancer 
screening is the best tool for detection of asymptomatic 
cancers and the results of the NELSON study are clearly 
supporting this view. 
Lung nodule morphology and changing morphology are 
important criteria that guide management; these criteria 
are best assessed with CT. One study which remeasured 
more than 400 subsolid nodules from the National Lung 
Screening Trial (NLSn data at baseline and follow-up 
imaging showed that the malignancy risks for these lesions 
were higher than previously reported.3 Larger subsolid 
lesions are also more likely to be malignant based on 
the same study. 
CONClUSION 
Lung cancer is common and has a higher death rate than 
most cancers. Low-dose lung CT scans have a high accuracy 
for detection of lung cancers and impact significantly on 
the disease outcome and on the patient's quality of life. 
Bi-yearly screening of high risk individuals is therefore 
highly recommended. 
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Clinks available for General Practitioners and Specialists at Rational Pharmacy, 74/75 Valley Road, B'Kara. 
No rental charges. 
For more information kindly send email on kcamilleri@cebpharma.com or call on 9989 1732 
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GENERAL PRACTITIONER REQUIRED 
General Practitioner required for Targa Health Clinics in Mosta to maintain 
continuity of care. Established clientele. 
For more information kindly contact: 
targa327@hotmail.com or 9944 0956 
